The findings reach mice, none yet in people. 3 independent labs in 3 countries; 3 trials.
None of its findings points the other way.
Cells and mice: a single group. Worms or flies and humans: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
Includes the processes named after it and trials of drugs aimed at it.
3 independent labs in 3 countries
3 trials
Funders: National Center for Advancing Translational Sciences and 8 more
1 of 5 findings with company ties
3 of 3 trials sponsored by developers of drugs aimed at it
Human trial2
Humans25
Animals12
Cells9
Interventions
2
Pracinostat
↑upin mouse cells1
1 study
Pracinostat increases TNNT2 in mouse cells (5-fold).
The model scored 0.822 in external validation, compared with 0.784 in training and 0.781 in internal testing, on a measure of its ability to distinguish disease.The model scored 0.822 in external validation, compared with 0.784 in training and 0.781 in internal testing, on a measure of its ability to distinguish disease.
Who was studied102 patients receiving peritoneal dialysis, 1 year, against the clinical-only model
What changedCardiovascular risk prediction scored higher with biomarkers plus clinical indicators: ROC-AUC 0.822 versus 0.780 with clinical indicators alone
The catchExcluding participants who died of non-cardiovascular causes could bias the model's predictions
Organ age gaps for the kidney, lung, and immune system predicted patient outcomes independently of standard clinical biomarkers.Organ age gaps for the kidney, lung, and immune system predicted patient outcomes independently of standard clinical biomarkers.